Lv21
120 积分 2024-09-03 加入
Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours
1小时前
待确认
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours
1小时前
已完结
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
3个月前
已完结
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
3个月前
已完结
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
3个月前
已完结
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
3个月前
已完结
Safety, tolerability, pharmacokinetics(PK) and pharmacodynamics(PD) of HSK31858，a novel DPP-1 inhibitor in healthy volunteers：a phase I clinical trial
1年前
已关闭
Safety, tolerability, pharmacokinetics(PK) and pharmacodynamics(PD) of HSK31858，a novel DPP-1 inhibitor in healthy volunteers：a phase I clinical trial
1年前
已关闭
皖公网安备34019202002308
